https://pharmadog.xyz/news/245942 pharmadog en 2026-08-14T18:34:30.000Z Pediatricians push back against vaccine fear-mongering by federal leaders https://pharmadog.xyz/news/245739 pharmadog en 2026-08-14T17:44:45.000Z Cytokinetics sues Bristol Myers Squibb over recently granted patent, intensifying rivalry https://pharmadog.xyz/news/245622 pharmadog en 2026-08-14T17:11:14.000Z Biotech firm Biogen secures Chinese approval for felzartamab in second-line multiple myeloma https://pharmadog.xyz/news/245450 pharmadog en 2026-08-14T16:30:39.000Z UnitedHealthcare CEO Brian Thompson killed; suspect Luigi Mangione pleads guilty to federal stalking https://pharmadog.xyz/news/245451 pharmadog en 2026-08-14T16:20:43.000Z Formation Bio appoints Michael Ehlers as chief scientific officer and head of R&D https://pharmadog.xyz/news/245351 pharmadog en 2026-08-14T16:02:00.000Z FDA grants accelerated approval to Bristol Myers' Zenbexus, first CELMoD for multiple myeloma https://pharmadog.xyz/news/245311 pharmadog en 2026-08-14T15:55:13.000Z FDA grants accelerated approval to Bristol's Zenbexus for multiple myeloma; PBMs adopt TrumpRx pricing; Novartis wins UK Entresto patent https://pharmadog.xyz/news/245130 pharmadog en 2026-08-14T15:33:45.000Z Capricor to submit additional data to FDA after negative advisory committee vote on Duchenne therapy https://pharmadog.xyz/news/245291 pharmadog en 2026-08-14T15:32:22.000Z Capricor Therapeutics sees stock surge as FDA signals openness to extend review of DMD cell therapy https://pharmadog.xyz/news/245131 pharmadog en 2026-08-14T15:30:52.000Z Redx Pharma pursues new reverse merger with Skye after 2023 setback https://pharmadog.xyz/news/245132 pharmadog en 2026-08-14T15:28:46.000Z Abcuro raises $66 million to launch Phase 3 trial in muscle-weakening disease after earlier setback https://pharmadog.xyz/news/245133 pharmadog en 2026-08-14T15:15:46.000Z ICER finds AstraZeneca’s blood pressure pill Baxfendy not cost-effective at $10,950 a year https://pharmadog.xyz/news/244914 pharmadog en 2026-08-14T14:10:55.000Z MapLight Therapeutics pauses early‑stage programs to focus on lead schizophrenia and Alzheimer’s psychosis candidate https://pharmadog.xyz/news/244819 pharmadog en 2026-08-14T14:00:17.000Z FDA approves Bristol Myers' first oral therapy for advanced multiple myeloma, a new drug class https://pharmadog.xyz/news/245095 pharmadog en 2026-08-14T13:28:00.000Z Capricor shares jump as FDA signals openness to review updated Duchenne therapy https://pharmadog.xyz/news/244682 pharmadog en 2026-08-14T13:23:06.000Z Drug-testing lab sues US Pharmacopeia over alleged false statements about testing methods https://pharmadog.xyz/news/245873 pharmadog en 2026-08-14T12:28:00.000Z Skye Bioscience and Redx Pharma combine to form Fibrx Therapeutics with $125M financing for fibrosis pipeline https://pharmadog.xyz/news/244435 pharmadog en 2026-08-14T12:03:41.000Z FDA clears Bristol Myers' Zenbexus, first drug of a new class for advanced multiple myeloma https://pharmadog.xyz/news/244287 pharmadog en 2026-08-14T11:36:52.000Z FDA grants accelerated approval to BMS’s iberdomide, branded Zenbexus, as generic competition hits Revlimid and Pomalyst sales https://pharmadog.xyz/news/244288 pharmadog en 2026-08-14T11:33:24.000Z EU regulator withdraws Amgen's Tavneos authorization over serious trial breaches https://pharmadog.xyz/news/244047 pharmadog en 2026-08-14T11:00:58.000Z Bicara appoints President Ryan Cohlhepp as CEO effective Jan. 1, while J&J veteran John Reed joins Madrigal board https://pharmadog.xyz/news/244160 pharmadog en 2026-08-14T11:00:00.000Z New state and federal funding fuels biotech hub growth in Pennsylvania, Kansas City and beyond https://pharmadog.xyz/news/245007 pharmadog en 2026-08-14T10:20:00.000Z BioCryst to rely on external partnerships after ending internal discovery programs https://pharmadog.xyz/news/244889 pharmadog en 2026-08-14T09:37:00.000Z Capricor plans FDA amendment after advisory committee rejects cardiomyopathy endpoint, stock jumps https://pharmadog.xyz/news/243601 pharmadog en 2026-08-14T08:30:00.000Z Methadone clinics show mixed progress two years after regulatory overhaul https://pharmadog.xyz/news/243602 pharmadog en 2026-08-14T08:30:00.000Z US and UK health systems both prioritize clinical care over community prevention, author warns https://pharmadog.xyz/news/243600 pharmadog en 2026-08-14T08:30:00.000Z Opinion: Car telematics warns of health-insurance data surveillance https://pharmadog.xyz/news/243599 pharmadog en 2026-08-14T08:30:00.000Z CMS rule blocks Medicaid funding for pediatric gender-affirming care, raising legal challenges https://pharmadog.xyz/news/243638 pharmadog en 2026-08-14T04:41:00.000Z MapLight shifts focus to schizophrenia drug after mixed Phase 2 results, raises $150 million https://pharmadog.xyz/news/242664 pharmadog en 2026-08-14T04:08:00.000Z Overseas MDMA and psilocybin makers eye U.S. market as regulatory landscape eases https://pharmadog.xyz/news/245204 pharmadog en 2026-08-14T00:00:00.000Z Industry groups urge FDA to add clarity and flexibility to manufacturer-payor communication guidance https://pharmadog.xyz/news/241295 pharmadog en 2026-08-13T21:49:09.000Z Commure ends referral payment program for its AI clinic tools https://pharmadog.xyz/news/241251 pharmadog en 2026-08-13T21:19:05.000Z FDA grants accelerated approval to Bristol Myers' iberdomide for relapsed or refractory multiple myeloma https://pharmadog.xyz/news/246453 pharmadog en 2026-08-13T18:49:00.000Z Grand Central Bakery recalls potato sourdough loaves over possible metal fragments https://pharmadog.xyz/news/240651 pharmadog en 2026-08-13T18:39:13.000Z European regulators withdraw Amgen's Tavneos over questionable data https://pharmadog.xyz/news/240534 pharmadog en 2026-08-13T18:31:07.000Z Epilepsy drug from Ovid and Takeda receives fresh start under Perceptive-backed venture https://pharmadog.xyz/news/240375 pharmadog en 2026-08-13T17:55:02.000Z FDA's PDUFA VIII adds 'America First' incentives and speeds up drug reviews https://pharmadog.xyz/news/240399 pharmadog en 2026-08-13T17:02:58.000Z FDA grants emergency use authorization for Simparica TRIO to treat New World screwworm in dogs and puppies https://pharmadog.xyz/news/239987 pharmadog en 2026-08-13T16:05:00.000Z Taiho and Cullinan report positive Phase 3 results for zipalertinib in EGFR exon 20 insertion lung cancer https://pharmadog.xyz/news/239988 pharmadog en 2026-08-13T15:10:00.000Z PTC Therapeutics agrees to pay up to $211 million for Sangamo’s experimental Fabry disease gene therapy https://pharmadog.xyz/news/239780 pharmadog en 2026-08-13T14:46:37.000Z Eli Lilly moves to curb black-market sales of retatrutide amid rising illicit demand https://pharmadog.xyz/news/239667 pharmadog en 2026-08-13T14:43:15.000Z Karyopharm faces default risk with only a month left to rescue cancer expansion https://pharmadog.xyz/news/239691 pharmadog en 2026-08-13T14:42:40.000Z Taiho and Cullinan’s zipalertinib shows progression‑free survival benefit in Phase 3 NSCLC trial https://pharmadog.xyz/news/239781 pharmadog en 2026-08-13T14:37:18.000Z Health secretary Kennedy pushes new addiction-treatment strategy in California, criticizes prior administration https://pharmadog.xyz/news/134233 pharmadog en 2026-08-13T14:26:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/244514 pharmadog en 2026-08-13T14:26:00.000Z Former Legend Biotech CEO Ying Huang appointed head of K2 Therapeutics https://pharmadog.xyz/news/239668 pharmadog en 2026-08-13T14:19:46.000Z Khartis Therapeutics secures $50 million Series B funding from Forge Life Science Partners, Longwood Fund and Lilly Asia Ventures https://pharmadog.xyz/news/239504 pharmadog en 2026-08-13T13:19:42.000Z California distributes over 120,000 low-cost insulin glargine packs as Novo Nordisk CEO warns investors on obesity drug differentiation https://pharmadog.xyz/news/239283 pharmadog en 2026-08-13T13:00:52.000Z Aligned Marketplace secures $20 million to link self-insured employers with primary-care clinics https://pharmadog.xyz/news/239210 pharmadog en 2026-08-13T12:29:26.000Z STAT+ probes Commure’s AI-driven health-care platform and Medicare’s new incentives for AI medical devices https://pharmadog.xyz/news/239051 pharmadog en 2026-08-13T11:49:16.000Z Zealand Pharma sells rights to rare blood cancer drug rusfertide for up to $100M https://pharmadog.xyz/news/238914 pharmadog en 2026-08-13T11:20:50.000Z Bankrupt Sangamo sells Fabry gene therapy to PTC and prion program to Lilly for $161M https://pharmadog.xyz/news/238890 pharmadog en 2026-08-13T11:11:47.000Z Taiho and Cullinan's zipalertinib clears Phase 3 trial in EGFR-mutated lung cancer https://pharmadog.xyz/news/238915 pharmadog en 2026-08-13T11:10:01.000Z Italy’s life‑science sector gains clinical strength and venture capital but still trails Europe’s leaders https://pharmadog.xyz/news/238674 pharmadog en 2026-08-13T10:30:26.000Z PTC Therapeutics and Eli Lilly to acquire parts of bankrupt Sangamo for up to $264 million https://pharmadog.xyz/news/238718 pharmadog en 2026-08-13T10:30:00.000Z Neurocrine’s rare-disease drug approved but later linked to deaths and serious side effects https://pharmadog.xyz/news/239642 pharmadog en 2026-08-13T09:56:00.000Z PDS Biotechnology pauses phase 3 head-and-neck trial to prioritize colorectal cancer immunotherapy https://pharmadog.xyz/news/238582 pharmadog en 2026-08-13T08:30:00.000Z Oxford study offers model showing statins pose minimal muscle disorder risk, a tool against health misinformation https://pharmadog.xyz/news/238579 pharmadog en 2026-08-13T08:30:00.000Z Patients with treatment-resistant depression weigh pros and cons of brain-implant devices https://pharmadog.xyz/news/238581 pharmadog en 2026-08-13T08:30:00.000Z Vaccines protect lives: A physician’s reminder of what we lose without them https://pharmadog.xyz/news/238580 pharmadog en 2026-08-13T08:30:00.000Z Medicare's new add-on payments for AI devices may spur hospital adoption and risk overuse https://pharmadog.xyz/news/238583 pharmadog en 2026-08-13T08:30:00.000Z New fertility options give young cancer survivors hope for parenthood https://pharmadog.xyz/news/238584 pharmadog en 2026-08-13T08:30:00.000Z California’s new CalRx insulin label aims for affordable access but faces slow rollout https://pharmadog.xyz/news/239369 pharmadog en 2026-08-13T08:16:00.000Z PTC Therapeutics acquires Sangamo’s Fabry gene therapy program for $111 million upfront https://pharmadog.xyz/news/237979 pharmadog en 2026-08-13T07:00:00.000Z Avalyn Pharma CEO shares personal moment as company prepares for Nasdaq IPO https://pharmadog.xyz/news/237980 pharmadog en 2026-08-13T07:00:00.000Z July biopharma layoffs down 94% YoY, 466 jobs cut across six companies https://pharmadog.xyz/news/238649 pharmadog en 2026-08-13T05:26:00.000Z Cullinan tees up J&J fight—and $100M payday—as Taiho-partnered drug hits phase 3 cancer goal https://pharmadog.xyz/news/238490 pharmadog en 2026-08-13T05:06:00.000Z Zealand Pharma sells its rights to Takeda's rusfertide for $100 million ahead of FDA decision https://pharmadog.xyz/news/240459 pharmadog en 2026-08-13T04:00:00.000Z Baxter recalls Duo-Vent IV solution sets over risk of air bubbles in patients https://pharmadog.xyz/news/239259 pharmadog en 2026-08-13T03:11:00.000Z Versa Vascular appoints former Medtronic heart franchise leader Bill Shields as CEO https://pharmadog.xyz/news/242477 pharmadog en 2026-08-13T00:00:00.000Z FDA releases draft PDUFA VIII commitment letter outlining goals and enhancements for 2028-2032 https://pharmadog.xyz/news/242479 pharmadog en 2026-08-13T00:00:00.000Z FDA schedules hearing on Concerta generic withdrawal as Ivonescimab secures first-line lung cancer indication in China https://pharmadog.xyz/news/242478 pharmadog en 2026-08-13T00:00:00.000Z European trade group urges authorities to grant notified bodies access to Eudamed for risk-based oversight https://pharmadog.xyz/news/236277 pharmadog en 2026-08-12T21:55:00.000Z Oma's Pride recalls one lot of Woof Complete Canine Chicken Recipe due to possible Salmonella contamination